Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
Shen J, Zhang W, Jin Q, Gong F, Zhang H, Xu H, Li J, Yao H, Jiang X, Yang Y, Hong L, Mei J, Song Y, Zhou S.
Shen J, et al. Among authors: zhang w, zhang h.
Oncol Res. 2023 Dec 28;32(2):339-351. doi: 10.32604/or.2023.030887. eCollection 2023.
Oncol Res. 2023.
PMID: 38186570
Free PMC article.